Français
ItalianoBond Bristol Myers-Squibb 4.5% ( US110122AX68 ) in USD
| Issuer | Bristol Myers-Squibb |
| Market price |  100 % ▲ |
| Country |  United States
|
| ISIN code |
 US110122AX68 ( in USD )
|
| Interest rate | 4.5% per year ( payment 2 times a year) |
| Maturity | 01/03/2044 |
|
Prospectus brochure in PDF format is unavailable at this time We will provide it as soon as possible |
|
| Minimal amount | 2 000 USD |
| Total amount | 500 000 000 USD |
| Cusip | 110122AX6 |
| Standard & Poor's ( S&P ) rating | A+ ( Upper medium grade - Investment-grade ) |
| Moody's rating | A2 ( Upper medium grade - Investment-grade ) |
| Next Coupon | 01/03/2026 ( In 21 days ) |
| Detailed description |
Bristol Myers Squibb is a global biopharmaceutical company engaged in the research, development, and marketing of innovative medicines and biotherapeutics across various therapeutic areas, including oncology, cardiovascular disease, immunology, and fibrosis. Bristol Myers Squibb issued a US$500,000,000 4.5% bond (CUSIP: 110122AX6, ISIN: US110122AX68) maturing on March 1, 2044, with a minimum purchase amount of $2,000, currently trading at 100% of par value, paying semi-annually, and rated A+ by S&P and A2 by Moody's. |